Next Quarterly Earnings
After-hours — after the market close (typically after 5:30 p.m. CET).
Zydus Lifesciences is a global pharmaceutical company from India, dedicated to the research, development, manufacturing, and marketing of comprehensive healthcare products. Its portfolio encompasses innovative medicines, generics, and biosimilars. Zydus enhances patient care worldwide through high-quality pharmaceutical solutions.
After-hours — after the market close (typically after 5:30 p.m. CET).
Zydus Lifesciences is scheduled to report its next quarterly earnings on 11/13/2026. After-hours — after the market close (typically after 5:30 p.m. CET).
Zydus Lifesciences last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at 9.10 INR.
Across its last 4 earnings reports, Zydus Lifesciences stock moved by ±2.7% on average the following day. The largest reaction was +4% on 02/09/2026; 3 of 4 reactions were positive.
Zydus Lifesciences has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.